Related Experiment Video

Updated: Jul 31, 2026

Development of an IFN-γ ELISpot Assay to Assess Varicella-Zoster Virus-specific Cell-mediated Immunity Following Umbilical Cord Blood Transplantation
08:04

Development of an IFN-γ ELISpot Assay to Assess Varicella-Zoster Virus-specific Cell-mediated Immunity Following Umbilical Cord Blood Transplantation

Published on: July 9, 2014

Long-term immunoprophylaxis for hepatitis B virus reinfection after liver transplantation

W C Lee1, L B Jeng, C C Wang

  • 1Department of Surgery, Chang Gung Memorial Hospital, Chang Gung Medical College, Taiwan, R.O.C.

Transplantation Proceedings
|June 1, 1996
PubMed
Abstract

No abstract available in PubMed .

More Related Videos

Stem Cell-Derived Viral Ag-Specific T Lymphocytes Suppress HBV Replication in Mice
07:25

Stem Cell-Derived Viral Ag-Specific T Lymphocytes Suppress HBV Replication in Mice

Published on: September 25, 2019

A Competent Hepatocyte Model Examining Hepatitis B Virus Entry through Sodium Taurocholate Cotransporting Polypeptide as a Therapeutic Target
11:34

A Competent Hepatocyte Model Examining Hepatitis B Virus Entry through Sodium Taurocholate Cotransporting Polypeptide as a Therapeutic Target

Published on: May 10, 2022

Related Experiment Videos

Last Updated: Jul 31, 2026

Development of an IFN-γ ELISpot Assay to Assess Varicella-Zoster Virus-specific Cell-mediated Immunity Following Umbilical Cord Blood Transplantation
08:04

Development of an IFN-γ ELISpot Assay to Assess Varicella-Zoster Virus-specific Cell-mediated Immunity Following Umbilical Cord Blood Transplantation

Published on: July 9, 2014

Stem Cell-Derived Viral Ag-Specific T Lymphocytes Suppress HBV Replication in Mice
07:25

Stem Cell-Derived Viral Ag-Specific T Lymphocytes Suppress HBV Replication in Mice

Published on: September 25, 2019

A Competent Hepatocyte Model Examining Hepatitis B Virus Entry through Sodium Taurocholate Cotransporting Polypeptide as a Therapeutic Target
11:34

A Competent Hepatocyte Model Examining Hepatitis B Virus Entry through Sodium Taurocholate Cotransporting Polypeptide as a Therapeutic Target

Published on: May 10, 2022

Related Concept Videos

Hepatitis01:25

Hepatitis

Hepatitis is an inflammatory condition of the liver most commonly caused by hepatotropic viruses (A–E), though non-infectious causes such as alcohol and drugs also exist.Hepatitis AHepatitis A virus (HAV) is a non-enveloped RNA virus of the Picornaviridae family. It is primarily transmitted via the fecal-oral route, typically through ingestion of contaminated food or water. After ingestion, HAV enters the bloodstream through the oropharynx or intestinal epithelium and reaches the liver. The...

Articles linked to this work by shared authors, journal, and citation graph.

Childhood-onset autosomal-dominant limb-girdle muscular dystrophy with cardiac conduction block.

Muscle & nerve·1997

Human babesiosis in Taiwan: asymptomatic infection with a Babesia microti-like organism in a Taiwanese woman.

Journal of clinical microbiology·1997

Lipid peroxidation in cord blood: the effects of umbilical nuchal cord.

British journal of obstetrics and gynaecology·1997

Does DsbA have chaperone-like activity?

Archives of biochemistry and biophysics·1997

Development and validation of a particle-enhanced turbidimetric inhibition assay for urine albumin on the Dade aca analyzer.

Clinical chemistry·1997

Trypanosoma brucei: identification of an internal region of phosphoglycerate kinase required for targeting to glycosomal microbodies.

Experimental parasitology·1997

Ten-Year Outcomes of Early Suboptimal Graft Function Following Deceased Donor Kidney Transplantation.

Transplantation proceedings·2026

Psychiatric and Identity Reconstruction Following Organ Transplantation: A Review of Patient-Attributed Donor-Related Experiences.

Transplantation proceedings·2026

Latent Profile Analysis of Symptom Experiences in Kidney Transplant Recipients and Their Differences in Health-Related Quality of Life: A Cross-Sectional Study.

Transplantation proceedings·2026

Survival of Hepatocellular Carcinoma After Liver Transplantation: Validation of Malatya Criteria.

Transplantation proceedings·2026

Knowledge Gaps and Educational Needs in Organ Donation: A Cross-Sectional Study Among Patients With End-Stage Renal Disease and Their Families.

Transplantation proceedings·2026

Risk Factors for Acute Kidney Injury After Conventional Open Liver Transplantation: A Single-Center Retrospective Cohort Study.

Transplantation proceedings·2026

Primary Liver Transplantation for Biliary Atresia: Another Piece of the Puzzle.

Pediatric transplantation·2026

Liver Transplantation for Gestational Alloimmune Liver Disease: Outcomes Analysis From Retrospective Cohort and National Case Series.

Pediatric transplantation·2026

Intragraft FOXP3+ Cells and Continuous Banff Indices in T Cell-Mediated Kidney Allograft Rejection.

Medicina (Kaunas, Lithuania)·2026

Safety of Biologic Therapy for Inflammatory Bowel Disease in Liver Transplant Recipients.

Biomedicines·2026

B3GALT5 regulates renal A/B antigen levels: a determinant of prognosis and rejection in ABO-incompatible kidney transplantation.

Journal of global health·2026

Hematopoietic stem cell transplantation for DOCK8 deficiency: durable immune reconstitution and long-term survival in 47 patients.

Frontiers in immunology·2026
See all related articles
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies
Jove
Visualize
Contact Us